177 related articles for article (PubMed ID: 17582603)
1. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells.
Ovalle S; Gutiérrez-López MD; Olmo N; Turnay J; Lizarbe MA; Majano P; Molina-Jiménez F; López-Cabrera M; Yáñez-Mó M; Sánchez-Madrid F; Cabañas C
Int J Cancer; 2007 Nov; 121(10):2140-52. PubMed ID: 17582603
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of CD9 does not affect in vivo tumorigenic or metastatic properties of human prostate cancer cells.
Zvieriev V; Wang JC; Chevrette M
Biochem Biophys Res Commun; 2005 Nov; 337(2):498-504. PubMed ID: 16198313
[TBL] [Abstract][Full Text] [Related]
3. Integrin alpha3 expression as a prognostic factor in colon cancer: association with MRP-1/CD9 and KAI1/CD82.
Hashida H; Takabayashi A; Tokuhara T; Taki T; Kondo K; Kohno N; Yamaoka Y; Miyake M
Int J Cancer; 2002 Feb; 97(4):518-25. PubMed ID: 11802216
[TBL] [Abstract][Full Text] [Related]
4. Cell surface tetraspanin CD9 mediates chemoresistance in small cell lung cancer.
Kohmo S; Kijima T; Otani Y; Mori M; Minami T; Takahashi R; Nagatomo I; Takeda Y; Kida H; Goya S; Yoshida M; Kumagai T; Tachibana I; Yokota S; Kawase I
Cancer Res; 2010 Oct; 70(20):8025-35. PubMed ID: 20940407
[TBL] [Abstract][Full Text] [Related]
5. Down-regulation of CD9 in human ovarian carcinoma cell might contribute to peritoneal dissemination: morphologic alteration and reduced expression of beta1 integrin subsets.
Furuya M; Kato H; Nishimura N; Ishiwata I; Ikeda H; Ito R; Yoshiki T; Ishikura H
Cancer Res; 2005 Apr; 65(7):2617-25. PubMed ID: 15805258
[TBL] [Abstract][Full Text] [Related]
6. GM3 ganglioside inhibits CD9-facilitated haptotactic cell motility: coexpression of GM3 and CD9 is essential in the downregulation of tumor cell motility and malignancy.
Ono M; Handa K; Sonnino S; Withers DA; Nagai H; Hakomori S
Biochemistry; 2001 May; 40(21):6414-21. PubMed ID: 11371204
[TBL] [Abstract][Full Text] [Related]
7. The tetraspanin CD9 modulates epidermal growth factor receptor signaling in cancer cells.
Murayama Y; Shinomura Y; Oritani K; Miyagawa J; Yoshida H; Nishida M; Katsube F; Shiraga M; Miyazaki T; Nakamoto T; Tsutsui S; Tamura S; Higashiyama S; Shimomura I; Hayashi N
J Cell Physiol; 2008 Jul; 216(1):135-43. PubMed ID: 18247373
[TBL] [Abstract][Full Text] [Related]
8. CD9 promotes adeno-associated virus type 2 infection of mammary carcinoma cells with low cell surface expression of heparan sulphate proteoglycans.
Kurzeder C; Koppold B; Sauer G; Pabst S; Kreienberg R; Deissler H
Int J Mol Med; 2007 Feb; 19(2):325-33. PubMed ID: 17203208
[TBL] [Abstract][Full Text] [Related]
9. A specific microdomain ("glycosynapse 3") controls phenotypic conversion and reversion of bladder cancer cells through GM3-mediated interaction of alpha3beta1 integrin with CD9.
Mitsuzuka K; Handa K; Satoh M; Arai Y; Hakomori S
J Biol Chem; 2005 Oct; 280(42):35545-53. PubMed ID: 16103120
[TBL] [Abstract][Full Text] [Related]
10. Endothelial cell-driven regulation of CD9 or motility-related protein-1 expression in multiple myeloma cells within the murine 5T33MM model and myeloma patients.
De Bruyne E; Andersen TL; De Raeve H; Van Valckenborgh E; Caers J; Van Camp B; Delaissé JM; Van Riet I; Vanderkerken K
Leukemia; 2006 Oct; 20(10):1870-9. PubMed ID: 16900214
[TBL] [Abstract][Full Text] [Related]
11. CD9 controls the formation of clusters that contain tetraspanins and the integrin alpha 6 beta 1, which are involved in human and mouse gamete fusion.
Ziyyat A; Rubinstein E; Monier-Gavelle F; Barraud V; Kulski O; Prenant M; Boucheix C; Bomsel M; Wolf JP
J Cell Sci; 2006 Feb; 119(Pt 3):416-24. PubMed ID: 16418227
[TBL] [Abstract][Full Text] [Related]
12. Profiling of the tetraspanin web of human colon cancer cells.
Le Naour F; André M; Greco C; Billard M; Sordat B; Emile JF; Lanza F; Boucheix C; Rubinstein E
Mol Cell Proteomics; 2006 May; 5(5):845-57. PubMed ID: 16467180
[TBL] [Abstract][Full Text] [Related]
13. Tetraspanin CD9 negatively regulates lipopolysaccharide-induced macrophage activation and lung inflammation.
Suzuki M; Tachibana I; Takeda Y; He P; Minami S; Iwasaki T; Kida H; Goya S; Kijima T; Yoshida M; Kumagai T; Osaki T; Kawase I
J Immunol; 2009 May; 182(10):6485-93. PubMed ID: 19414803
[TBL] [Abstract][Full Text] [Related]
14. Anti-CD9 monoclonal antibody-stimulated invasion of endometrial cancer cell lines in vitro: possible inhibitory effect of CD9 in endometrial cancer invasion.
Park KR; Inoue T; Ueda M; Hirano T; Higuchi T; Konishi I; Fujiwara H; Fujii S
Mol Hum Reprod; 2000 Aug; 6(8):719-25. PubMed ID: 10908282
[TBL] [Abstract][Full Text] [Related]
15. The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin.
Cook GA; Wilkinson DA; Crossno JT; Raghow R; Jennings LK
Exp Cell Res; 1999 Sep; 251(2):356-71. PubMed ID: 10471321
[TBL] [Abstract][Full Text] [Related]
16. A functionally relevant conformational epitope on the CD9 tetraspanin depends on the association with activated beta1 integrin.
Gutierrez-Lopez MD; Ovalle S; Yanez-Mo M; Sanchez-Sanchez N; Rubinstein E; Olmo N; Lizarbe MA; Sanchez-Madrid F; Cabanas C
J Biol Chem; 2003 Jan; 278(1):208-18. PubMed ID: 12411441
[TBL] [Abstract][Full Text] [Related]
17. Tetraspanin CD9 regulates beta 1 integrin activation and enhances cell motility to fibronectin via a PI-3 kinase-dependent pathway.
Kotha J; Longhurst C; Appling W; Jennings LK
Exp Cell Res; 2008 May; 314(8):1811-22. PubMed ID: 18358474
[TBL] [Abstract][Full Text] [Related]
18. Tetraspanin CD9 is involved in the migration of retinal microvascular endothelial cells.
Deissler H; Kuhn EM; Lang GE; Deissler H
Int J Mol Med; 2007 Nov; 20(5):643-52. PubMed ID: 17912457
[TBL] [Abstract][Full Text] [Related]
19. Native type IV collagen induces cell migration through a CD9 and DDR1-dependent pathway in MDA-MB-231 breast cancer cells.
Castro-Sanchez L; Soto-Guzman A; Navarro-Tito N; Martinez-Orozco R; Salazar EP
Eur J Cell Biol; 2010 Nov; 89(11):843-52. PubMed ID: 20709424
[TBL] [Abstract][Full Text] [Related]
20. Differential display cloning identifies motility-related protein (MRP1/CD9) as highly expressed in primary compared to metastatic human colon carcinoma cells.
Cajot JF; Sordat I; Silvestre T; Sordat B
Cancer Res; 1997 Jul; 57(13):2593-7. PubMed ID: 9205061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
